Insiders · Profile

Sorrento Therapeutics, Inc.

10% owner at Celularity · 10% owner at Scilex. Filing since 21 Sep 2023. CIK 0000850261

Company
Date
Role
Action
Shares
Amount
Of holding
5 Oct 2023
10% owner
Sold at will
6,307,158
no price
55.5%
29 Sep 2023
10% owner
Sold at will
9,064,539
no price
44.4%
21 Sep 2023
10% owner
Sold at will
60,068,585
no price
96.9%
3 decisions on file.